CPEB3 and hepatocellular carcinoma: MiR-18a-5p is upregulated in hepatocellular carcinoma, and its overexpression significantly promotes tumor cell growth, while miR-18a-5p acts as an oncogenic factor to accelerate the malignant phenotype of hepatocellular carcinoma by inhibiting CPEB3 [7].